Physician profile
Lisa Brown
NPI 1427164540
$1,162.48
in general payments reported to CMS, 2019-2025
23 companies · $142 in 2025
The $142 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $191 · 2020: $160 · 2021: $212 · 2022: $239 · 2023: $85.98 · 2024: $132 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $360.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $173.99 | 2022-2024 | Jornay Pm |
| Pfizer INC. | $142.48 | 2019-2025 | |
| Tris Pharma INC | $126.44 | 2019-2024 | Dyanavel Xr |
| Sanofi Pasteur INC. | $97.44 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $77.11 | 2021-2025 | Qelbree, Qelbree |
| Corium, LLC | $73.86 | 2023-2025 | Azstarys, Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $63.90 | 2020-2022 | |
| Teva Pharmaceuticals USA, INC. | $50.15 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $48.78 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $42.00 | 2022 | |
| Phadia US INC. | $37.13 | 2021-2025 | Immunocap |
| Neos Therapeutics, Lp | $29.83 | 2019-2020 | |
| Kaleo, INC. | $29.14 | 2019 | |
| Baxter Healthcare | $28.75 | 2024 | Hillrom - Digital Macroview Otoscope, Hillrom - Connex Spot Monitor |
| Ars Pharmaceuticals Operations, INC. | $21.89 | 2025 | Neffy |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $19.57 | 2021 | |
| Cognoa, INC. | $17.10 | 2021 | |
| Lnhc, INC | $16.97 | 2025 | Zelsuvmi |
| Sanofi-Aventis U.S. LLC | $14.47 | 2025 | |
| Glaxosmithkline, LLC. | $14.26 | 2021 | |
| Arbor Pharmaceuticals, INC. | $13.87 | 2019 | |
| Vertical Pharmaceuticals, LLC | $12.00 | 2020 | |
| Shire North American Group INC | $11.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.